The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Access · International

Personal import allowances, compared

Wiki
BA
b.adeyemiTL2 Moderator16 Dec 2025#1
Community wiki post. Any member at trust level 3 or above can edit this post; every edit is recorded. Last edited by a.reyes on 21 Apr 2026.
  • 16 Mar 2026 — g.pemberton_uk: Added the worked example and a unit label to the table header.
  • 29 Jan 2026 — PharmNotes_Whitfield: Clarified the distinction that was causing repeat questions below.
  • 21 Apr 2026 — a.reyes: Removed a claim that the cited source did not support.
Editors: g.pemberton_uk, PharmNotes_Whitfield, a.reyes, j.delacroix

On the subject in the title: Personal import allowances, compared Working notes rather than a conclusion.

Documenting an access outcome, dated, because everything in this category expires.

As of July 2026, in my region, the position is as described below. I have linked the primary source rather than a summary of it, because the summaries are consistently a year behind.

If anyone can confirm or contradict this for their own region, please date your answer. An undated claim in this category is worse than no claim.

0 likes 7mo
N
NardoneTL2Member17 Dec 2025#2

Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not eliminate) risk.

3 likes 7mo
NK
n.kaufmannTL2 Moderator18 Dec 2025#3

Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when in doubt.

11 likes 7mo
AK
a.kwiatkowskiTL2Member18 Dec 2025#4
n.kaufmann, post #3: Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when in doubt. Go to post

On post #2 — agreed on the reasoning, with one qualification.

Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.

23 likes in reply to #3 7mo
SC
s.chowdhuryTL3Regular19 Dec 2025#5

Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before ordering is prudent.

0 likes 7mo
I
IRenaudinTL2Member20 Dec 2025 · edited#6

Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is unclear.

1 like 7mo
EB
e.bakkenTL2 Moderator20 Dec 2025#7

post #6 is right about the mechanism and I think understates the practical bit.

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

0 likes 7mo
MM
methods_marginTL3Regular21 Dec 2025#8
IRenaudin, post #6: Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is unclear. Go to post

Worth separating two things that post #4 runs together.

Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more predictive than theory.

3 likes in reply to #6 7mo
NB
n.boatengTL2 Moderator21 Dec 2025#9
e.bakken, post #7: post #6 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this,… Go to post

Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.

3 likes in reply to #7 7mo
CR
crossover_reviewTL3Regular22 Dec 2025#10

Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.

10 likes 7mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Second pass at: Cross-border purchase within the EU: the actual rules
Posting this under the heading it deserves: Second pass at: Cross-border purchase within the EU: the actual rules Everything below is what sits behind that. Documenting an access outcome, dated, because…
KVMSZILOWM+135 139 8.7k 16mo
Revisiting: Language barriers in accessing a prescription abroad
Posting this under the heading it deserves: Revisiting: Language barriers in accessing a prescription abroad Everything below is what sits behind that. Documenting an access outcome, dated, because everything…
MMLSSLMIMH+131 148 28k 5mo
About the International category
Country-by-country availability and legality, dated because it changes constantly. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
TVDOPMAN+6 11 240 22mo
Language barriers in accessing a prescription abroad
Language barriers in accessing a prescription abroad Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in this…
KBMAMR 2 22k 1h
What changed in 2026, by region
What changed in 2026, by region — that is the question, and I have not found it answered plainly anywhere I have looked. Documenting an access outcome, dated, because everything in this category expires. As…
AFNDCNNNID+110 122 1.4k 18mo

Related topics — sharing the tags EMA, MHRA, telehealth

TopicParticipantsRepliesViewsActivity
Coming back to: Cross-border purchase rules within the EU
Cross-border purchase rules within the EU Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what…
JEDBNRPFFE+12 16 2.8k 11mo
Second pass at: When your prescriber and the evidence disagree
Second pass at: When your prescriber and the evidence disagree — setting out what I have, and where I think it stops being reliable. General question, not a request for advice about my own care — I know the…
BNMONRPFB+51 55 9.2k 2d
MHRA statements, read directly
MHRA statements, read directly Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what determines the…
VMSOGHTVJ+93 101 2.2k 5mo
Second pass at: Import rules for personal quantities, by jurisdiction, dated
Second pass at: Import rules for personal quantities, by jurisdiction, dated Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are…
DHKAV 2 5k 11mo
Discussing something you have already been doing — the long version
Discussing something you have already been doing — the long version Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
ITATALENG+14 18 58k 12mo